Core A: Administrative Core
核心A:行政核心
基本信息
- 批准号:10203851
- 负责人:
- 金额:$ 15.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-26 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AchievementAdvocacyAdvocateBasic ScienceCancer BiologyClinicalClinical ResearchCollaborationsCommunicationConflict (Psychology)ConsultationsDataDevelopmentDisputesEnsureEvaluationFoundationsFundingFutureGoalsGovernmentGrantHuman ResourcesHuman Subject ResearchInfrastructureInstitutionLaboratory FindingLeadershipMalignant neoplasm of lungMonitorNational Cancer InstituteOccupational activity of managing financesPatientsPhilanthropic FundPreparationPrincipal InvestigatorPrivatizationProgram EvaluationProgress ReportsPublicationsRegulationResearchResearch PersonnelResearch PriorityResourcesSeriesSourceTimeTimeLineTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesYale Cancer Centeranticancer researchcareercost effectivemeetingsneoplasm resourcenoveloperationoutreachpersonalized medicineprogramssuccesssymposiumtranslational cancer researchwebsite development
项目摘要
CORE SUMMARY
The Administrative Core (Core A) is directed by Roy Herbst, Principal Investigator of the Yale SPORE in Lung
Cancer (YSILC), and co-directed by Ed Kaftan, with support from the program financial management team.
Careful oversight by the Administrative Core will be critical to ensure the success of the Yale SPORE in Lung
Cancer. Core A is an extension of existing infrastructure provided by YCC Research Administration to support
and facilitate transdisciplinary research efforts. The Administrative Core serves as the central coordination
point for all YSILC investigators, with responsibility for monitoring the progress of all projects and cores toward
a translational/clinical endpoint. The Core Director and Co-Director along with the YISLC Co-PI (Dr. Chen)
have responsibility for leading the YSILC program, setting translational research priorities, identifying new
translational research opportunities from emerging data, monitoring the progress of all projects, cores and
developmental projects and determining changes in direction of projects, cores and translational research as
needed. Interactions among YSILC investigators is facilitated by Core A to accelerate the translation of
laboratory findings into the proposed and future clinical studies. If required, the Core A Director will manage
conflicts among YSILC investigators. As a team, the Core personnel monitors finances, maintains
communications among project and core leaders and coordinates meetings, including the weekly lung cancer
translational group seminar series, monthly meetings of the Executive Committee, annual meetings of the
Internal/External Advisory boards and the annual YSILC SEP and DRP Symposium. In addition to these
functions, the Core is the primary interface with the NCI, other lung cancer SPOREs, Yale Cancer Center and
Yale University, and coordinates outreach efforts, including publications (internal and external), website
development, seminars, patient/research advocacy activities, and fundraising programs. Through these
administrative activities, Core A is essential to the organization of the YSILC program, to developing a
widespread culture of lung cancer basic/clinical/translational research at Yale and to the efficient achievement
of the stated program objectives, with the ultimate goal of a significant clinical impact for patients with lung
cancer.
核心摘要
管理核心(核心A)由耶鲁大学肺部孢子的首席研究员罗伊·赫布斯特(Roy Herbst)指导
癌症(YSILC),并共同导演的艾德卡夫坦,与支持的计划财务管理团队。
行政核心的仔细监督对于确保耶鲁大学在龙的SPORE的成功至关重要
癌核心A是YCC研究管理局提供的现有基础设施的扩展,
并促进跨学科的研究工作。行政核心作为中央协调机构
所有YSILC调查员的一个点,负责监控所有项目和核心的进展,
转化/临床终点。核心总监和联席总监沿着YISLC联席主要研究者(陈博士)
负责领导YSILC计划,确定转化研究的优先事项,确定新的
从新兴的数据转化研究的机会,监测所有项目的进展,核心和
发展项目和确定项目方向的变化,核心和转化研究,
needed.核心A促进了YSILC研究者之间的互动,以加快
将实验室结果纳入拟议和未来的临床研究。如果需要,核心A主管将管理
YSILC调查员之间的冲突。作为一个团队,核心人员监控财务,
项目和核心领导人之间的沟通,并协调会议,包括每周肺癌
翻译小组研讨会系列,执行委员会每月会议,
内部/外部咨询委员会和年度YSILC SEP和DRP研讨会。除了这些
核心是与NCI、其他肺癌SPORE、耶鲁癌症中心和
耶鲁大学,并协调外联工作,包括出版物(内部和外部)、网站
发展,研讨会,患者/研究宣传活动和筹款计划。通过这些
行政活动,核心A是必不可少的组织YSILC计划,制定一个
耶鲁大学肺癌基础/临床/转化研究的广泛文化,
声明的计划目标,最终目标是对肺部疾病患者产生重大临床影响,
癌
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roy S Herbst其他文献
Ultrastructural
- DOI:
10.1038/labinvest.2012.25 - 发表时间:
2012-02-01 - 期刊:
- 影响因子:0
- 作者:
Vamsidhar Velcheti;Kurt A Schalper;Daniel E Carvajal;Valsamo K Anagnostou;Konstantinos N Syrigos;Mario Sznol;Roy S Herbst;Scott N Gettinger;Lieping Chen;David L Rimm - 通讯作者:
David L Rimm
The end of the beginning: progress and next steps in emKRAS/em-mutant non-small-cell lung cancer
开端的终结:emKRAS/em 突变型非小细胞肺癌的进展与下一步措施
- DOI:
10.1016/s0140-6736(23)00288-x - 发表时间:
2023-03-04 - 期刊:
- 影响因子:88.500
- 作者:
Sarah B Goldberg;Roy S Herbst - 通讯作者:
Roy S Herbst
Pan-genomic/Pan-proteomic Approaches to Diseases
- DOI:
10.1038/labinvest.2012.19 - 发表时间:
2012-02-01 - 期刊:
- 影响因子:0
- 作者:
Vamsidhar Velcheti;Kurt A Schalper;Daniel E Carvajal;Valsamo K Anagnostou;Konstantinos N Syrigos;Mario Sznol;Roy S Herbst;Scott N Gettinger;Lieping Chen;David L Rimm - 通讯作者:
David L Rimm
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
芦比替定联合阿替利珠单抗作为广泛期小细胞肺癌一线维持治疗的疗效与安全性(IMforte):一项随机、多中心、开放标签的3期试验
- DOI:
10.1016/s0140-6736(25)01011-6 - 发表时间:
2025-06-14 - 期刊:
- 影响因子:88.500
- 作者:
Luis Paz-Ares;Hossein Borghaei;Stephen V Liu;Solange Peters;Roy S Herbst;Katarzyna Stencel;Margarita Majem;Mehmet Ali Nahit Şendur;Grzegorz Czyżewicz;Reyes Bernabé Caro;Ki Hyeong Lee;Melissa L Johnson;Nuri Karadurmuş;Christian Grohé;Sofia Baka;Tibor Csőszi;Jin Seok Ahn;Raffaele Califano;Tsung-Ying Yang;Yasemin Kemal;Martin Reck - 通讯作者:
Martin Reck
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol
在 Lung-MAP Master Protocol 中重新分析临床 DNA 测序数据以进行生物标志物匹配的过程
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
J.W. Neal;K. Minichiello;Ryan Brennick;Richard S P Huang;Matthew C. Hiemenz;Cornel Amler;Jyoti D. Patel;Roy S Herbst;K. Reckamp;Hossein Borghaei;Louise Highleyman;M. Redman;L. Pasquina;D. Kozono - 通讯作者:
D. Kozono
Roy S Herbst的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roy S Herbst', 18)}}的其他基金
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
耶鲁 SPORE 肺癌 (YSILC):肺癌的生物学和个性化治疗
- 批准号:
10203850 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
Yale SPORE in Lung Cancer Developmental Research Program
耶鲁大学 SPORE 肺癌发展研究项目
- 批准号:
10203857 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
耶鲁 SPORE 肺癌 (YSILC):肺癌的生物学和个性化治疗
- 批准号:
9767058 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
耶鲁 SPORE 肺癌 (YSILC):肺癌的生物学和个性化治疗
- 批准号:
9338869 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
耶鲁 SPORE 肺癌 (YSILC):肺癌的生物学和个性化治疗
- 批准号:
8931829 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
MicroRNA-based interventions to prevent progression from lung preneoplasia to adenocarcinoma
基于 MicroRNA 的干预措施可预防肺肿瘤前期发展为腺癌
- 批准号:
9379210 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
相似海外基金
Transfer Advocacy Groups: Transforming Culture to Support Community College Transfer Students of Color in Undergraduate Physics
转学倡导团体:转变文化以支持社区学院本科物理有色人种转学生
- 批准号:
2224295 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Continuing Grant
Engaging adolescents for sexual and reproductive health and rights and family planning advocacy in Pakistan.
让巴基斯坦青少年参与性健康和生殖健康及权利以及计划生育宣传。
- 批准号:
490127 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Operating Grants
Developing a network for mutual learning on the potential of creative arts for mental health advocacy and activism in Ghana and Indonesia
建立一个网络,以相互学习创意艺术在加纳和印度尼西亚促进心理健康倡导和行动的潜力
- 批准号:
AH/X009637/1 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Research Grant
Protection without Advocacy: Japan's Failure to Support Persons with Mental Disabilities in the community
没有倡导的保护:日本未能支持社区中的精神残疾人
- 批准号:
23K01937 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Developing a cultural adaptation framework for youth mental health education and advocacy initiatives at Jack.org
Jack.org 为青少年心理健康教育和宣传活动制定文化适应框架
- 批准号:
484618 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Fellowship Programs
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
- 批准号:
10683644 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Lupus and health information: Evidence-informed advocacy in action
狼疮和健康信息:循证宣传在行动
- 批准号:
485670 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Miscellaneous Programs
Initiating Meaningful Partnerships for Advocacy and Collaborative Training: The IMPACT initiative
发起有意义的倡导和协作培训伙伴关系:IMPACT 倡议
- 批准号:
487847 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Miscellaneous Programs
Creating advocacy and tech to make secondhand first choice.
创造宣传和技术,让二手货成为首选。
- 批准号:
10064859 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Collaborative R&D
Advocacy Strategies supporting Social Determinants of Health: Paving the Path to Community Reintegration and Recovery
支持健康问题社会决定因素的倡导策略:为社区重新融入和恢复铺平道路
- 批准号:
480718 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




